Abstract:Recently, molecular generation models based on deep learning have attracted significant attention in drug discovery. However, most existing molecular generation models have serious limitations in the context of drug design wherein they do not sufficiently consider the effect of the three-dimensional (3D) structure of the target protein in the generation process. In this study, we developed a new deep learning-based molecular generator, SBMolGen, that integrates a recurrent neural network, a Monte Carlo tree search, and docking simulations. The results of an evaluation using four target proteins (two kinases and two G protein-coupled receptors) showed that the generated molecules had a better binding affinity score (docking score) than the known active compounds, and the generated molecules possessed a broader chemical space distribution. SBMolGen not only generates novel binding active molecules but also presents 3D docking poses with target proteins, which will be useful in subsequent drug design. The code is available at <a class="extLink" href="https://github.com/clinfo/SBMolGen">https://github.com/clinfo/SBMolGen</a>.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jcim.1c00679?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jcim.1c00679</a>.Number of generated molecules, example of generated molecules for target EGFR at C = 1.0, example of generated molecules for target AA2AR at C = 1.0, example of generated molecules for target ADRB2 at C = 1.0; distribution of the similarity score of the generated molecules and distribution of the scaffold similarity score of the generated molecules; distribution of the SA scores of the generated molecules; distributions of the QED scores of the generated molecules; plots of IFIE<sub>sum</sub> against experimentally determined Δ<i>G</i> for (A) nine CDK2 inhibitors and (B) generated molecules; distribution of the docking scores of the generated molecules against DDR1; chemical structures of nine CDK2 inhibitors and their properties (<a class="ext-link" href="/doi/suppl/10.1021/acs.jcim.1c00679/suppl_file/ci1c00679_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

DenovoProfiling: A webserver for de novo generated molecule library profiling

DrugGen: a Database of De Novo-Generated Molecular Binders for Specified Target Proteins.

Generating and screening de novo compounds against given targets using ultrafast deep learning models as core components

Electron-density informed effective and reliable de novo molecular design and lead optimization with ED2Mol

ChemMapper: a Versatile Web Server for Exploring Pharmacology and Chemical Structure Association Based on Molecular 3D Similarity Method

Status and Prospects of Research on Deep Learning-based De Novo Generation of Drug Molecules

ReMODE: a Deep Learning-Based Web Server for Target-Specific Drug Design

Structure-Based de Novo Molecular Generator Combined with Artificial Intelligence and Docking Simulations

Gene4Denovo: an Integrated Database and Analytic Platform for De Novo Mutations in Humans

Deep Generative Models in De Novo Drug Molecule Generation

Novopathfinder: a Webserver of Designing Novel-Pathway with Integrating GEM-model

Prospective de novo drug design with deep interactome learning

<i>De novo</i> drug design framework based on mathematical programming method and deep learning model

ChemGenerator: a web server for generating potential ligands for specific targets

An explainable deep learning platform for molecular discovery

Molecular generation strategy and optimization based on A2C reinforcement learning in de novo drug design

ChemDes: an Integrated Web-Based Platform for Molecular Descriptor and Fingerprint Computation

QPowered Compound2DeNovoDrugPropMax –A Novel Programmatic Tool Incorporating Deep Learning and In Silico Methods for Automated In Silico Bio- Activity Discovery for any Compound of Interest

DNMG: Deep Molecular Generative Model by Fusion of 3D Information for De Novo Drug Design.

Multi-Objective De Novo Drug Design with Conditional Graph Generative Model

Structure-based <i>de novo</i> drug design using 3D deep generative models